Skip to main content

DarioHealth Corp.

For the period ended Dec 31, 2025. Filed Mar 19, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 19, 2026

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 19, 2026DARIOHEALTH CORP.
By:/s/ Erez Raphael
Name:Erez Raphael
Title:Chief Executive Officer
By:/s/ Chen Franco-Yehuda
Name:Chen Franco-Yehuda
Title:Chief Financial Officer, Secretary and Treasurer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Person​ ​ ​Capacity​ ​ ​Date
/s/ Erez RaphaelChief Executive Officer andMarch 19, 2026
Erez RaphaelDirector (Principal Executive Officer)
/s/ Chen Franco YehudaChief Financial Officer, Secretary andMarch 19, 2026
Chen Franco YehudaTreasurer (Principal Financial and Accounting Officer)
/s/ Yoav ShakedChairman of the BoardMarch 19, 2026
Yoav Shaked
/s/ Dennis MatheisDirectorMarch 19, 2026
Dennis Matheis
/s/ Hila KarahDirectorMarch 19, 2026
Hila Karah
/s/ Dennis M. McGrathDirectorMarch 19, 2026
Dennis M. McGrath
/s/ Lawrence LeisureDirectorMarch 19, 2026
Lawrence Leisure
​​​​​
/s/ Adam SternDirectorMarch 19, 2026
Adam Stern

CONSOLIDATED FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2025

INDEX

​ ​ ​Page
Reports of Independent Registered Public Accounting Firm (PCAOB - Firms ID: 1309, 1281)​F-2 – F-4
​
Consolidated Balance Sheets​F-5 – F-6
​
Consolidated Statements of Comprehensive Loss​F-7
​
Statements of Changes in Stockholders’ Equity​F-8
​
Consolidated Statements of Cash Flows​F-9
​
Notes to Consolidated Financial Statements​F-10 – F-56
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.